undefined

< Back to search results

Optimal sequencing of enzalutamide and abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer : a multicentre, randomised, open-label, phase 2, crossover trial

Year of publication

2019

Authors

Khalaf, DJ;Kollmannsberger, CK;Eigl, BJ;Noonan, K;Wadhwa, D;Attwell, A;Keith, B;Ellard, SL;Le, L;Gleave, ME;Wyatt, AW;Annala, M;Chi, KN;Taavitsainen, S;Finch, DL;Oja, C;Vergidis, J;Zulfiqar, M;Sunderland, K;Azad, AA

Organizations and authors

Tampere University

Annala M

Taavitsainen S

Publication type

Publication format

Article

Parent publication type

Journal

Article type

Original article

Audience

Scientific

Peer-reviewed

Peer-Reviewed

MINEDU's publication type classification code

A1 Journal article (refereed), original research

Publication channel information

Journal

The Lancet Oncology

Volume

20

Issue

12

Pages

p1730-1739

ISSN

1470-2045

​Publication forum

62403

​Publication forum level

3

Open access

Open access in the publisher’s service

No

Self-archived

Yes

Other information

Fields of science

Biomedicine; Cancers

Internationality of the publisher

International

Language

English

International co-publication

Yes

Co-publication with a company

No

DOI

10.1016/S1470-2045(19)30688-6

The publication is included in the Ministry of Education and Culture’s Publication data collection

Yes